Jeffrey S. Hatfield Insider Trading $AMBI AMBIT BIOSCIENCES CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeffrey S. Hatfield.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeffrey S. Hatfield. Jeffrey S. Hatfield is Director in AMBIT BIOSCIENCES CORP ($AMBI) and Chief Executive Officer in Vitae Pharmaceuticals, Inc ($VTAE) and Director in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV) and Director in aTYR PHARMA INC ($LIFE) and Chief Executive Officer in ZAFGEN, INC. ($ZFGN) and Director in MIRAGEN THERAPEUTICS, INC. ($MGEN) and Director in Vir Biotechnology, Inc. ($VIR).

Jeffrey S. Hatfield in AMBIT BIOSCIENCES CORP

Trading Symbol: AMBI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey S. Hatfield: Director
Holdings: 0 shares
Latest Transaction: Nov 12 2014

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jeffrey S. Hatfield in AMBIT BIOSCIENCES CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMBI, LIFE, NVIV, LRMR, VIR, MGEN, VTAE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 12 2014AMBIAMBIT BIOSCIENCES ...Hatfield Jeffrey S.DirectorOption ExerciseD6.6914,00093,6600

Page:   1